BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 36672325)

  • 1. Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia.
    Della Starza I; De Novi LA; Elia L; Bellomarino V; Beldinanzi M; Soscia R; Cardinali D; Chiaretti S; Guarini A; Foà R
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances.
    Della Starza I; Chiaretti S; De Propris MS; Elia L; Cavalli M; De Novi LA; Soscia R; Messina M; Vitale A; Guarini A; Foà R
    Front Oncol; 2019; 9():726. PubMed ID: 31448230
    [No Abstract]   [Full Text] [Related]  

  • 3. Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?
    Assanto GM; Del Giudice I; Della Starza I; Soscia R; Cavalli M; Cola M; Bellomarino V; Di Trani M; Guarini A; Foà R
    Front Oncol; 2023; 13():1152467. PubMed ID: 36998457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia.
    Nunes V; Cazzaniga G; Biondi A
    Expert Rev Mol Diagn; 2017 Nov; 17(11):953-963. PubMed ID: 28891364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferring measurable residual disease measurement in pediatric acute lymphoblastic leukemia from quantitative real-time PCR to digital droplet PCR.
    Luib L; Kreyenberg H; Michaelis S; Handgretinger R; Mezger M
    Pediatr Transplant; 2023 Jun; 27(4):e14483. PubMed ID: 36750990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing the prognostic impact of minimal residual disease in treatment decisions for pediatric acute lymphoblastic leukemia.
    Ceppi F; Rizzati F; Colombini A; Conter V; Cazzaniga G
    Expert Rev Hematol; 2021 Sep; 14(9):795-807. PubMed ID: 34374613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?
    Kotrova M; Trka J; Kneba M; Brüggemann M
    Mol Diagn Ther; 2017 Oct; 21(5):481-492. PubMed ID: 28452038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis between RQ-PCR and digital-droplet-PCR of immunoglobulin/T-cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia.
    Della Starza I; Nunes V; Cavalli M; De Novi LA; Ilari C; Apicella V; Vitale A; Testi AM; Del Giudice I; Chiaretti S; Foà R; Guarini A
    Br J Haematol; 2016 Aug; 174(4):541-9. PubMed ID: 27172403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Specific Assays Based on Whole-Genome Sequencing Data to Measure Residual Disease in Children With Acute Lymphoblastic Leukemia: A Proof of Concept Study.
    Arthur C; Rezayee F; Mogensen N; Saft L; Rosenquist R; Nordenskjöld M; Harila-Saari A; Tham E; Barbany G
    Front Oncol; 2022; 12():899325. PubMed ID: 35865473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia.
    Della Starza I; De Novi LA; Santoro A; Salemi D; Spinelli O; Tosi M; Soscia R; Paoloni F; Cappelli LV; Cavalli M; Apicella V; Bellomarino V; Di Lello E; Vitale A; Vignetti M; Fabbiano F; Rambaldi A; Bassan R; Guarini A; Chiaretti S; Foà R
    J Mol Diagn; 2022 Aug; 24(8):893-900. PubMed ID: 35710027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia.
    Della Starza I; Nunes V; Lovisa F; Silvestri D; Cavalli M; Garofalo A; Campeggio M; De Novi LA; Soscia R; Oggioni C; Mussolin L; Biondi A; Guarini A; Valsecchi MG; Conter V; Biffi A; Basso G; Foà R; Cazzaniga G
    Hemasphere; 2021 Mar; 5(3):e543. PubMed ID: 33655199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?
    Del Giudice I; Raponi S; Della Starza I; De Propris MS; Cavalli M; De Novi LA; Cappelli LV; Ilari C; Cafforio L; Guarini A; Foà R
    Front Oncol; 2019; 9():689. PubMed ID: 31555576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a PCR-Based Next-Generation Sequencing Approach for the Detection and Quantification of Minimal Residual Disease in Acute Lymphoblastic Leukemia and Multiple Myeloma Using gBlocks as Calibrators.
    Van der Straeten J; De Brouwer W; Kabongo E; Dresse MF; Fostier K; Schots R; Van Riet I; Bakkus M
    J Mol Diagn; 2021 May; 23(5):599-611. PubMed ID: 33549860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New View on Minimal Residual Disease Quantification in Acute Lymphoblastic Leukemia using Droplet Digital PCR.
    Schwinghammer C; Koopmann J; Chitadze G; Karawajew L; Brüggemann M; Eckert C
    J Mol Diagn; 2022 Aug; 24(8):856-866. PubMed ID: 35691569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia.
    Ansuinelli M; Della Starza I; Lauretti A; Elia L; Siravo V; Messina M; De Novi LA; Taherinasab A; Canichella M; Guarini A; Foà R; Chiaretti S
    Hematol Oncol; 2021 Dec; 39(5):680-686. PubMed ID: 34402088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal/Measurable Residual Disease Monitoring in
    Forghieri F; Comoli P; Marasca R; Potenza L; Luppi M
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
    Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia.
    Kruse A; Abdel-Azim N; Kim HN; Ruan Y; Phan V; Ogana H; Wang W; Lee R; Gang EJ; Khazal S; Kim YM
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of minimal residual disease in pediatric acute lymphoblastic leukemia.
    Gaipa G; Basso G; Biondi A; Campana D
    Cytometry B Clin Cytom; 2013; 84(6):359-69. PubMed ID: 23757107
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.